established in 2011 and operated business Original Equipment Manufacturer or OEM for skincare, cosmetics, supplementary food and skin medicine under trademarks including trademark of “DERMALIS”, (which will be

skin medicine under trademarks including trademark of “DERMALIS”, (which will be Criterion Calculation Method Transaction size 1. Net tangible assets (NTA) Proportion of assets acquired (100%) x NTA AT

) Gross profit 439.4 427.9 11.5 2.7 Net gain on exchange rate 55.1 112.2 (57.1) (50.9) Gain on forward contracts 11.2 49.5 (38.3) (77.4) Other income 2.0 173.0 (171.0) (98.8) Profit before expenses 507.7

32.6 Debt Service Coverage 904.1 4.4 103.9 4.6 Total Debt to Equity 0.2 0.4 0.2 0.4 * calculated by using earnings of current quarter to be estimated for annual earnings ** based on only cost of medicine

operations for 2nd Quarter of 2017 decreased to 71.69%, while it was 74.38% for the 2nd Quarter of 2016. These resulted from the efficiency of medicine and medical supplies cost management, introducing an

personnel to support its expansion such as Cardiac Medicine department and Opthalmology department. Selling Expenses For the 6-month periods of 2015 and 2016 , the Company and its subsidiary incurred selling

Totabl Debt to Equity 0.13 0.25 * based on only cost of medicine & medical supplies

medicine & medical supplies

53.7 Debt Service Coverage 673.5 10.1 Total Debt to Equity 0.2 0.3 * calculated by using earnings of current quarter to be estimated for annual earnings ** based on only cost of medicine & medical

scrap materials and tax cards income. 4. Profit from foreign exchanges increased by 77.69 million baht (from 27.75 million baht in 2016 to 105.44 million baht in 2017) due to forward foreign currency